These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32253665)

  • 1. Prognostic implications of TdT expression in acute myeloid leukemia with an intermediate-risk karyotype.
    Saburi M; Ogata M; Satou T; Soga Y; Itani K; Kohno K; Kondo Y; Nakayama T
    Int J Hematol; 2020 Jul; 112(1):17-23. PubMed ID: 32253665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia.
    De Bellis E; Ottone T; Mercante L; Falconi G; Cugini E; Consalvo MI; Travaglini S; Paterno G; Piciocchi A; Rossi ELL; Gurnari C; Maurillo L; Buccisano F; Arcese W; Voso MT
    Leuk Res; 2020 Dec; 99():106462. PubMed ID: 33091616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TdT expression in acute myeloid leukemia with minimal differentiation is associated with distinctive clinicopathological features and better overall survival following stem cell transplantation.
    Patel KP; Khokhar FA; Muzzafar T; James You M; Bueso-Ramos CE; Ravandi F; Pierce S; Medeiros LJ
    Mod Pathol; 2013 Feb; 26(2):195-203. PubMed ID: 22936064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia.
    Drexler HG; Sperling C; Ludwig WD
    Leukemia; 1993 Aug; 7(8):1142-50. PubMed ID: 7688837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.
    Del Poeta G; Venditti A; Stasi R; Aronica G; Cox MC; Buccisano F; Tamburini A; Bruno A; Maurillo L; Battaglia A; Suppo G; Epiceno AM; Del Moro B; Masi M; Amadori S; Papa G
    Leuk Res; 1999 May; 23(5):451-65. PubMed ID: 10374859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
    Damiani D; Tiribelli M; Franzoni A; Michelutti A; Fabbro D; Cavallin M; Toffoletti E; Simeone E; Fanin R; Damante G
    Am J Hematol; 2013 Oct; 88(10):848-52. PubMed ID: 23760853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia.
    Foa R; Casorati G; Giubellino MC; Basso G; Schirò R; Pizzolo G; Lauria F; Lefranc MP; Rabbitts TH; Migone N
    J Exp Med; 1987 Mar; 165(3):879-90. PubMed ID: 3102679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic Value of CD123 in Acute Myeloid Leukemia Patients with Intermediate Risk in Normal Karyotype].
    Zhang Y; Liu RY; Wang SJ; Wang C; Zhang QT; He C; Xie XS; Wan DM; Jiang ZX; Liu YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1880-1884. PubMed ID: 33283714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia.
    Bertazzoni U; Brusamolino E; Isernia P; Scovassi AI; Torsello S; Lazzarino M; Bernasconi C
    Blood; 1982 Sep; 60(3):685-92. PubMed ID: 7049266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of terminal transferase activity and glucocorticoid receptor levels in acute myeloid leukemia.
    Skoog L; Ost A; Biberfeld P; Christensson B; Hast R; Lagerlöf B; Nordenskjöld B; Reizenstein P
    Br J Cancer; 1984 Oct; 50(4):443-9. PubMed ID: 6593093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.
    El-Sharnouby JA; Ahmed LM; Taha AM; Kamal O
    Egypt J Immunol; 2008; 15(1):131-43. PubMed ID: 20306678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of terminal transferase (TdT) in acute lymphocytic leukaemia expressing myeloid antigens and TdT positive acute myeloid leukaemia as compared to myeloid antigen negative acute lymphocytic leukaemia.
    Paietta E; Racevskis J; Bennett JM; Wiernik PH
    Br J Haematol; 1993 Jul; 84(3):416-22. PubMed ID: 8217792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.
    Lee EJ; Yang J; Leavitt RD; Testa JR; Civin CI; Forrest A; Schiffer CA
    Leukemia; 1992 Nov; 6(11):1203-9. PubMed ID: 1279324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma.
    Zhou Y; Fan X; Routbort M; Cameron Yin C; Singh R; Bueso-Ramos C; Thomas DA; Milton DR; Medeiros LJ; Lin P
    Mod Pathol; 2013 Oct; 26(10):1338-45. PubMed ID: 23702731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission: a retrospective survey on behalf of the ALWP of the EBMT.
    Brands-Nijenhuis AV; Labopin M; Schouten HC; Volin L; Socié G; Cornelissen JJ; Huynh A; Ljungman P; Malard F; Esteve J; Nagler A; Mohty M
    Haematologica; 2016 Feb; 101(2):248-55. PubMed ID: 26589909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features and early treatment effects in intermediate risk and poor risk acute myeloid leukemia with EVI1 positive].
    Duan WB; Gong LZ; Jia JS; Zhu HH; Zhao XS; Jiang Q; Zhao T; Wang J; Qin YZ; Huang XJ; Jiang H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):990-995. PubMed ID: 29263470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia.
    Chang H; Salma F; Yi QL; Patterson B; Brien B; Minden MD
    Leuk Res; 2004 Jan; 28(1):43-8. PubMed ID: 14630079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminal deoxynucleotidyl transferase in acute myeloid leukaemia.
    Jani P; Verbi W; Greaves MF; Bevan D; Bollum F
    Leuk Res; 1983; 7(1):17-29. PubMed ID: 6572772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytogentic and prognostic characteristic of acute myeloid leukemia with monosomal karyotype].
    Li Z; Wei H; Lin D; Zhou CL; Liu BC; Wang Y; Liu KQ; Li W; Gong BF; Wei SN; Zhang GJ; Zhao XL; Li Y; Liu YT; Gong XY; Gu RX; Qiu SW; Mi YC; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):366-71. PubMed ID: 27210869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.